Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Alliance predicts positive full-year results

This article was originally published in Scrip

Executive Summary

Alliance Pharma had a turnover of £21.8 million last year and expects to exceed market expectations for its full-year results, which will be released in March. Turnover in the second half of last year was £11.9 million, an increase of 20% compared with the first half of the year. Alliance now expects pre-tax trading profits of at least £2.3 million. Michael Gatenby, Alliance's chairman, said the company's sales were mainly prescription driven and were therefore largely unaffected by economic conditions. Existing shareholder Nigel Wray has purchased a further one million ordinary shares at 1p each. Mr Wray, who also owns the rugby club Saracens and has a £78 million stake in Domino's Pizza UK & Ireland, now holds around 12.2 million Alliance shares, equivalent to 7.5% of the company's issued share capital.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts